文献速递小儿泌尿与泌尿修复

探索儿童日间尿失禁的遗传风险:一项全基因组关联研究

Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study.
PubMed 文献 · J Urol · 2024-08-02

该研究在丹麦iPSYCH2015队列中开展全基因组关联研究,纳入3024例日间尿失禁(DUI)病例和30240例对照,并在冰岛deCODE队列(5475例病例/287773例对照)中重复验证。发现6号染色体rs12210989(OR 1.24,95%CI 1.17-1.32,P=3.21×10⁻¹²)和20号染色体rs4809801(OR 1.18,95%CI 1.11-1.25,P=3.66×10⁻⁸)达到全基因组显著性,涉及PRDM13和RIPOR3基因。常见遗传变异贡献于儿童DUI风险,这些发现可能有助于指导新治疗靶点的识别。

要点

  • 6号染色体rs12210989与DUI相关(OR 1.24,95%CI 1.17-1.32,P=3.21×10⁻¹²),涉及PRDM13基因。
  • 20号染色体rs4809801与DUI相关(OR 1.18,95%CI 1.11-1.25,P=3.66×10⁻⁸),涉及RIPOR3基因。
  • DUI与注意缺陷/多动障碍多基因风险(OR 1.098,95%CI 1.046-1.152,P<.0001)和BMI多基因风险(OR 1.129,95%CI 1.081-1.178,P<.0001)相关。

核心结论

  • 常见遗传变异贡献于儿童日间尿失禁的风险,涉及神经元发育和逼尿肌平滑肌活动的重要基因,这些发现可能有助于指导新治疗靶点的识别。

研究设计与样本

  • 在丹麦iPSYCH2015队列中开展全基因组关联研究,病例3024例(5至20岁,通过DUI诊断代码和DUI药物处方识别),对照30240例(从同一样本选取,按性别和精神病学诊断匹配,按1:10病例对照比降采样)。
  • 在冰岛deCODE队列(5475例病例/287773例对照)中进行重复验证。
  • 采用基于基因组限制性最大似然法计算单核苷酸多态性遗传力,采用连锁不平衡得分回归估计跨性状遗传相关性,采用LDpred2-auto和BOLT-LMM生成多基因风险评分并评估关联。

主要发现

  • 6号染色体变异rs12210989达到全基因组显著性(OR 1.24,95%CI 1.17-1.32,P=3.21×10⁻¹²),涉及PRDM13基因。
  • 20号染色体变异rs4809801达到全基因组显著性(OR 1.18,95%CI 1.11-1.25,P=3.66×10⁻⁸),涉及RIPOR3基因。
  • 6号染色体发现得到重复验证(P=.024,OR 1.09,95%CI 1.01-1.16)。
  • 责任尺度遗传力范围为10.20%(95%CI 6.40%-14.00%)至15.30%(95%CI 9.66%-20.94%)。
  • DUI与夜间遗尿症呈正向遗传相关(rg=1.28±0.38,P=.0007);DUI与注意缺陷/多动障碍多基因风险(OR 1.098,95%CI 1.046-1.152,P<.0001)和BMI多基因风险(OR 1.129,95%CI 1.081-1.178,P<.0001)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Childhood incontinence is stigmatized and underprioritized, and a basic understanding of its pathogenesis is missing. Our goal was to identify risk-conferring genetic variants in daytime urinary incontinence (DUI). MATERIALS AND METHODS: We conducted a genome-wide association study in the Danish iPSYCH2015 cohort. Cases (3024) were identified through DUI diagnosis codes and redeemed prescriptions for DUI medication in individuals aged 5 to 20 years. Controls (30,240), selected from the same sample, were matched to cases on sex and psychiatric diagnoses, if any, and down-sampled to a 1:10 case:control ratio. Replication was performed in the Icelandic deCODE cohort (5475 cases/287,773 controls). Single-nucleotide polymorphism heritability was calculated using the genome-based restricted maximum likelihood method. Cross-trait genetic correlation was estimated using linkage disequilibrium score regression. Polygenic risk scores generated with LDpred2-auto and BOLT-LMM were assessed for association. RESULTS: Variants on chromosome 6 (rs12210989, odds ratio [OR] 1.24, 95% CI 1.17-1.32, P = 3.21 × 10-12) and 20 (rs4809801, OR 1.18, 95% CI 1.11-1.25, P = 3.66 × 10-8) reached genome-wide significance and implicated the PRDM13 and RIPOR3 genes. Chromosome 6 findings were replicated (P = .024, OR 1.09, 95% CI 1.01-1.16). Liability scale heritability ranged from 10.20% (95% CI 6.40%-14.00%) to 15.30% (95% CI 9.66%-20.94%). DUI and nocturnal enuresis showed positive genetic correlation (rg = 1.28 ± 0.38, P = .0007). DUI was associated with attention-deficit/hyperactivity disorder (OR 1.098, 95% CI 1.046-1.152, P < .0001) and BMI (OR 1.129, 95% CI 1.081-1.178, P < .0001) polygenic risk. CONCLUSIONS: Common genetic variants contribute to the risk of childhood DUI, and genes important in neuronal development and detrusor smooth muscle activity were implicated. These findings may help guide identification of new treatment targets.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Breinbjerg A, Jørgensen CS, Walters GB, et al. Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study. J Urol. 2024. PMID: 39093873. doi:10.1097/JU.0000000000004187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。